Pluri Inc. (TLV:PLUR)

Revenue by Product

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2016	Jun 30, 2015
Placenta-Based Cell Therapy	326.00K
Placenta-Based Cell Therapy Growth	13.59%

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2016	Jun 30, 2015
Israel	326.00K
Israel Growth	13.59%